Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vera Therapeutics, Inc.

22.65
-0.6400-2.75%
Post-market: 22.650.00000.00%19:15 EDT
Volume:2.68M
Turnover:61.08M
Market Cap:1.44B
PE:-7.55
High:23.38
Open:23.19
Low:22.28
Close:23.29
Loading ...
Jun 24, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 24, 2021

Major Issues Report

8-K - Current report
Jun 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 28, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 27, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
May 24, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
May 24, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
May 18, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 18, 2021

Major Issues Report

8-K - Current report
May 12, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 12, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 12, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 12, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 10, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 23, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 23, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933